结果显示，系统性注射FAST-PLV递送的follistatin DNA，可显著提高血液中卵泡抑素的水平，并显著增加肌肉质量和握力。 基于队列4的积极结果，Jeune ...

Founded in 2015, BioViva Science aims to leverage gene therapy to prevent, treat, or reverse the processes underpinning the most common diseases in the developed world: aging-associated NCDs.

Their target: follistatin gene therapy,' he continued. 'A pioneering technology with the potential to improve muscle and strength [and] slow the speed of aging and many more benefits.' He revealed ...

Data show that follistatin gene therapy using proteolipid vehicles increases muscle mass, body weight, and grip strength in a preclinical model Publication details the development of the Entos ...

Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding episodes drop by an average of 71 percent after a single infusion of gene therapy, according to the new results of an ...

U.S. patent is first in industry to fully enable practical development of stem cell therapies for treating heart damage following a heart attack. Celebration Stem Cell Centre (CSSC) selects STEMSOFT’s ...

Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular ...

By September, at least 30 people worldwide had begun a one-time gene therapy outside trials, according to the two drugmakers whose therapies were approved in America. Both treatments involve a ...

Gene therapy could help obese kids avoid health problems associated with excess weight, including arthritis, a new, preliminary study in mice suggests. The gene therapy prompts cells to convert ...

Gene therapy holds promise for treating some of these conditions, and current research advances may soon shift the therapeutic landscape for eye health. However, many obstacles remain in place ...

And, despite the pandemic, 2020 was a landmark year for the 24-year-old, from County Durham, who became the first person in the UK to receive a revolutionary new gene therapy on the NHS.